Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Henrich

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cellular and Molecular Life Sciences : CMLS|February 17, 2019
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastomaAroa Soriano, Marc Masanas, Ariadna Boloix, et al.
Cell Death & Disease|August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomasSonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
Oncotarget|December 18, 2015
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaDavid J Duffy, Aleksandar Krstic, Melinda Halasz, et al.
Life Science Alliance|March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastomaElena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Leukemia|November 5, 2022
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistanceAnna-Katharina Wirth, Lucas Wange, Sebastian Vosberg, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Nature Communications|February 25, 2021
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteomeSabine A Hartlieb, Lina Sieverling, Michal Nadler-Holly, et al.
Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cellular and Molecular Life Sciences : CMLS|February 17, 2019
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastomaAroa Soriano, Marc Masanas, Ariadna Boloix, et al.
Cell Death & Disease|August 25, 2025
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomasSonja Herter, Marta Emperador, Kyriaki Smyrilli, et al.
Oncotarget|December 18, 2015
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaDavid J Duffy, Aleksandar Krstic, Melinda Halasz, et al.
Life Science Alliance|March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastomaElena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
Cancer Research|September 17, 2016
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Sebastian Bender, Maral Saadati, et al.
Leukemia|November 5, 2022
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistanceAnna-Katharina Wirth, Lucas Wange, Sebastian Vosberg, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Nature Communications|February 25, 2021
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteomeSabine A Hartlieb, Lina Sieverling, Michal Nadler-Holly, et al.
Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.
Pageof 5